AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30541745 — intervention group
Group type: EXPERIMENTAL
Intervention: Vyxeos (liposomal daunorubicin and cytarabine)
Number of subjects: 309
Study 30541745 — intervention group
Group type: COMPARATOR
Intervention: Standard combination of daunorubicin and cytarabine ('7+3')
Number of subjects: 309
Study 28964827 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity, low-load (HVLL) resistance exercise
Number of subjects: 9
Study 28964827 — intervention group
Group type: COMPARATOR
Intervention: Low-velocity, high-load (LVHL) resistance exercise
Number of subjects: 9
Study 27111003 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossword puzzles incorporating 30 veterinary terms
Number of subjects: 42
Study 27111003 — intervention group
Group type: COMPARATOR
Intervention: Rote learning with a list of 30 terms and definitions
Number of subjects: 42
Study 24948348 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events (≥ 1 major stressor)
Number of subjects: 497
Study 24948348 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events (≥ 4 major stressors)
Number of subjects: 497
Study 24948348 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to major stressful life events
Number of subjects: 497
Study 20604812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary dentures (MCD) using two implant-ball attachments (BC)
Number of subjects: 35
Study 20604812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary dentures (MCD) using four implants-bar attachments (BRC)
Number of subjects: 35
Study 20604812 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant-retained overdentures (MIRO) with maxillary fixed partial dentures (MFPD) using two implant-ball attachments (BF)
Number of subjects: 35
Study 20038840 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 876
Study 20038840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 876
Study 18230393 — intervention group
Group type: EXPERIMENTAL
Intervention: Apicectomy with smoothening of the gutta-percha root filling
Number of subjects: 42
Study 18230393 — intervention group
Group type: EXPERIMENTAL
Intervention: Apicectomy with retrograde root filling with mineral trioxide aggregate (MTA)
Number of subjects: 42
Study 18230393 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall perception of postoperative discomfort
Number of subjects: 42
Study 15960212 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management of a labor program (n = 325)
Number of subjects: 975
Study 15960212 — intervention group
Group type: COMPARATOR
Intervention: Conventional management (n = 650)
Number of subjects: 975
Study 12650955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 33
Study 12650955 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 33
Study 12650955 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 33
Study 12650955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 10229957 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine prevalence as assessed by the questionnaire 'Alcoi-92'
Number of subjects: 548
Study 10229957 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine characteristics as assessed by the questionnaire 'Alcoi-92'
Number of subjects: 548
Study 10229957 — intervention group
Group type: EXPERIMENTAL
Intervention: Associated symptoms of migraine
Number of subjects: 548
Study 10229957 — intervention group
Group type: EXPERIMENTAL
Intervention: Prodromal symptoms of migraine
Number of subjects: 548
Study 8924287 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (0.5%)
Number of subjects: 101
Study 8924287 — intervention group
Group type: COMPARATOR
Intervention: Topical gentamicin (0.3%)
Number of subjects: 101
Study 1929137 — intervention group
Group type: EXPERIMENTAL
Intervention: Vialon cannula
Number of subjects: 54
Study 1929137 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE-Teflon cannula
Number of subjects: 54
Study 1929137 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study 6822143 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.1 mg twice daily
Number of subjects: 0
Study 6822143 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2 mg twice daily (for those not achieving blood pressure goals)
Number of subjects: 0
Study 6822143 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg twice daily
Number of subjects: 0
Study 6822143 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg twice daily (for those not achieving blood pressure goals)
Number of subjects: 0
Study 6822143 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine during mental stress testing
Number of subjects: 0
Study 6822143 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide during mental stress testing
Number of subjects: 0
Study 31826195 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation associated with Taigeiko practice (16 sessions)
Number of subjects: 16
Study 31826195 — intervention group
Group type: COMPARATOR
Intervention: Taigeiko alone (control group)
Number of subjects: 16
Study 29151376 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 137
Study 29151376 — intervention group
Group type: COMPARATOR
Intervention: Bipolar tonsillectomy
Number of subjects: 137
Study 27156201 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 264
Study 27156201 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (PP-EES)
Number of subjects: 264
Study 24695934 — intervention group
Group type: COMPARATOR
Intervention: Community‐based orthopaedic surgeons
Number of subjects: 18
Study 24695934 — intervention group
Group type: COMPARATOR
Intervention: Postgraduate year‐5 residents
Number of subjects: 18
Study 24695934 — intervention group
Group type: COMPARATOR
Intervention: Postgraduate year‐1 residents
Number of subjects: 18
Study 22567655 — intervention group
Group type: EXPERIMENTAL
Intervention: Active self-ligating bracket system
Number of subjects: 70
Study 22567655 — intervention group
Group type: COMPARATOR
Intervention: Passive self-ligating bracket system
Number of subjects: 70
Study 18783774 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol (LDL-C)
Number of subjects: 4694
Study 18783774 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-high-density lipoprotein cholesterol (non-HDL-C)
Number of subjects: 4694
Study 18783774 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-C and non-HDL-C
Number of subjects: 4694
Study 17136461 — intervention group
Group type: EXPERIMENTAL
Intervention: electronic Check‐Up to Go (e‐CHUG)
Number of subjects: 106
Study 17136461 — intervention group
Group type: COMPARATOR
Intervention: assessment only (control)
Number of subjects: 106
Study 17136461 — intervention group
Group type: EXPERIMENTAL
Intervention: additional 245 abstainers and light drinkers
Number of subjects: 106
Study 15321806 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 kcal preload
Number of subjects: 24
Study 15321806 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 kcal preload
Number of subjects: 24
Study 15321806 — intervention group
Group type: COMPARATOR
Intervention: 0 kcal preload (water)
Number of subjects: 24
Study 15321806 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient preloads (250 kcal and 750 kcal)
Number of subjects: 24
Study 11295632 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐hydroxyphenyl retinamide (4‐HPR)
Number of subjects: 0
Study 11295632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9425919 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous acetic acid injection (50% acetic acid)
Number of subjects: 60
Study 9425919 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous ethanol injection (absolute ethanol)
Number of subjects: 60
Study 7852977 — intervention group
Group type: EXPERIMENTAL
Intervention: Only children
Number of subjects: 917
Study 7852977 — intervention group
Group type: COMPARATOR
Intervention: Sibling children
Number of subjects: 917
Study 30864645 — intervention group
Group type: EXPERIMENTAL
Intervention: sucrose
Number of subjects: 0
Study 30864645 — intervention group
Group type: EXPERIMENTAL
Intervention: sucrose + maltodextrin
Number of subjects: 0
Study 30864645 — intervention group
Group type: COMPARATOR
Intervention: deionized distilled water (DDW)
Number of subjects: 0
Study 30864645 — intervention group
Group type: COMPARATOR
Intervention: maltodextrin
Number of subjects: 0
Study 29141373 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% ropivacaine and 15 μg/ml hydromorphone (H1 group)
Number of subjects: 140
Study 29141373 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10% ropivacaine and 15 μg/ml hydromorphone (H2 group)
Number of subjects: 140
Study 29141373 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine and 15 μg/ml hydromorphone (H3 group)
Number of subjects: 140
Study 29141373 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% ropivacaine plus 20 μg/ml hydromorphone (first 50 women)
Number of subjects: 140
Study 26591685 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisia vulgaris moxa
Number of subjects: 38
Study 26591685 — intervention group
Group type: EXPERIMENTAL
Intervention: Charcoal moxa
Number of subjects: 38
Study 23873339 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (5 °C ice bath for 20 min)
Number of subjects: 20
Study 23873339 — intervention group
Group type: COMPARATOR
Intervention: Control (no cryotherapy)
Number of subjects: 20
Study 21147156 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 steps (10K)
Number of subjects: 43
Study 21147156 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minutes (30 min) of continuous physical activity
Number of subjects: 43
Study 21147156 — intervention group
Group type: COMPARATOR
Intervention: 30-minutes of activity in bouts of at least 10 minutes (bouts)
Number of subjects: 43
Study 21147156 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 43
Study 19110953 — intervention group
Group type: EXPERIMENTAL
Intervention: TVT-S surgical method
Number of subjects: 85
Study 17151159 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 314
Study 17151159 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 314
Study 17151159 — intervention group
Group type: COMPARATOR
Intervention: Switching antipsychotics
Number of subjects: 314
Study 15529059 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR plus an automated external defibrillator (AED)
Number of subjects: 993
Study 15529059 — intervention group
Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 993
Study 11423920 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Monounsaturated Fatty Acid Diet (H-MUFA)
Number of subjects: 27
Study 11423920 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (H-CHO)
Number of subjects: 27
Study 8996292 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction
Number of subjects: 0
Study 8425236 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (0.5 mg)
Number of subjects: 84
Study 8425236 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (5 ml)
Number of subjects: 84
Study 3320099 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate
Number of subjects: 10
Study 3320099 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide
Number of subjects: 10
Study 3320099 — intervention group
Group type: EXPERIMENTAL
Intervention: saline
Number of subjects: 10
Study 3320099 — intervention group
Group type: COMPARATOR
Intervention: non-irrigation
Number of subjects: 10
Study 29032494 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide + insulin
Number of subjects: 30
Study 29032494 — intervention group
Group type: COMPARATOR
Intervention: Insulin only
Number of subjects: 30
Study 27498355 — intervention group
Group type: EXPERIMENTAL
Intervention: BiP 5 mg
Number of subjects: 24
Study 27498355 — intervention group
Group type: EXPERIMENTAL
Intervention: BiP 15 mg
Number of subjects: 24
Study 27498355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27498355 — intervention group
Group type: EXPERIMENTAL
Intervention: BiP 1 mg
Number of subjects: 24
Study 27498355 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 24
Study 27498355 — intervention group
Group type: EXPERIMENTAL
Intervention: BiP (5 mg and 15 mg)
Number of subjects: 24
Study 26583145 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace physical exercise (WORK) performed in groups during working hours for 5 × 10 minutes per week
Number of subjects: 200
Study 26583145 — intervention group
Group type: COMPARATOR
Intervention: Home-based physical exercise (HOME) performed during leisure time for 5 × 10 minutes per week
Number of subjects: 200
Study 23532990 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-Based Intervention (FBI)
Number of subjects: 147
Study 23532990 — intervention group
Group type: COMPARATOR
Intervention: General Health Intervention (GHI)
Number of subjects: 147
Study 20628280 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure hemorrhoidectomy
Number of subjects: 68
Study 20628280 — intervention group
Group type: COMPARATOR
Intervention: Stapled hemorrhoidopexy
Number of subjects: 68
Study 18854062 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention (experimental condition)
Number of subjects: 525
Study 18854062 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 525
Study 16621911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (5.0 pmol/kg.min) during hyperinsulinemic euglycemic clamp
Number of subjects: 10
Study 16621911 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 10
Study 16621911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (5.0 pmol/kg.min)
Number of subjects: 10
Study 14647221 — intervention group
Group type: EXPERIMENTAL
Intervention: Water and sanitation facilities
Number of subjects: 25483
Study 14647221 — intervention group
Group type: COMPARATOR
Intervention: No water and sanitation facilities
Number of subjects: 25483
Study 10798540 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-RH agonist monotherapy (leuprorelin acetate depot, 3.75 mg monthly)
Number of subjects: 151
Study 10798540 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-RH agonist in combination with chlormadinone acetate (100 mg/day)
Number of subjects: 151
Study 8619447 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus tetracycline (AT)
Number of subjects: 176
Study 8619447 — intervention group
Group type: COMPARATOR
Intervention: Quinine plus tetracycline (QT)
Number of subjects: 176
Study 1558340 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy plus ranitidine
Number of subjects: 109
Study 1558340 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine alone
Number of subjects: 109
Study 3894147 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemeprost (1 mg vaginal pessary)
Number of subjects: 0
Study 3894147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31765223 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Emotional Freedom Techniques (EFT) intervention over 8 weeks
Number of subjects: 0
Study 29743076 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Mile intervention
Number of subjects: 391
Study 27238921 — intervention group
Group type: EXPERIMENTAL
Intervention: POD treatment (scaling, root planing, and subantimicrobial dose doxycycline)
Number of subjects: 22
Study 27238921 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to doxycycline therapy
Number of subjects: 22
Study 25062582 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral balanced occlusion
Number of subjects: 10
Study 25062582 — intervention group
Group type: COMPARATOR
Intervention: Neutrocentric occlusion
Number of subjects: 10
Study 25062582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both occlusal schemes
Number of subjects: 10
Study 22239416 — intervention group
Group type: COMPARATOR
Intervention: Conventional vaginal native tissue repair
Number of subjects: 121
Study 22239416 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal mesh insertion
Number of subjects: 121
Study 19783106 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and psychosocial treatment for alcohol dependence
Number of subjects: 345
Study 19783106 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and psychosocial treatment for comorbid alcohol and cocaine dependence
Number of subjects: 345
Study 19783106 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 345
Study 19041569 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated liposomal doxorubicin (PL-DOX)
Number of subjects: 16
Study 19041569 — intervention group
Group type: COMPARATOR
Intervention: Conventional echocardiography
Number of subjects: 16
Study 16267634 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (589.7 mg/day)
Number of subjects: 44
Study 16267634 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (4.9 mg/day)
Number of subjects: 44
Study 12164745 — intervention group
Group type: EXPERIMENTAL
Intervention: UV‐B phototherapy (3-times weekly narrowband TL‐01 UV‐B regimen)
Number of subjects: 41
Study 12164745 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients awaiting UV‐B therapy)
Number of subjects: 41
Study 10087313 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 44
Study 10087313 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 20 microg/kg
Number of subjects: 44
Study 7772441 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 30 mg
Number of subjects: 66
Study 7772441 — intervention group
Group type: EXPERIMENTAL
Intervention: lansoprazole 60 mg
Number of subjects: 66
Study 7772441 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 66
Study 2193199 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment (1 unit.kg bw‐1.hr‐1)
Number of subjects: 0
Study 2193199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 0
Study 148436 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gels
Number of subjects: 0
Study 148436 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream
Number of subjects: 0
Study 148436 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30155866 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel two‐thumb technique (NTTT)
Number of subjects: 52
Study 30155866 — intervention group
Group type: COMPARATOR
Intervention: Standard two‐finger technique (TFT)
Number of subjects: 52
Study 27664940 — intervention group
Group type: EXPERIMENTAL
Intervention: Pocket PATH exposure during year 1
Number of subjects: 182
Study 27664940 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 182
Study 27664940 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting abnormal health indicators to clinicians
Number of subjects: 182
Study 26228496 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid applied to one side during tonsillectomy
Number of subjects: 50
Study 26228496 — intervention group
Group type: COMPARATOR
Intervention: Control side (no hyaluronic acid)
Number of subjects: 50
Study 23928929 — intervention group
Group type: EXPERIMENTAL
Intervention: PSG TKA (group 1)
Number of subjects: 180
Study 23928929 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA (group 2)
Number of subjects: 180
Study 21407131 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min vibration at 100 Hz applied to the Achilles tendon
Number of subjects: 8
Study 21407131 — intervention group
Group type: COMPARATOR
Intervention: Rest (control experiment)
Number of subjects: 8
Study 19894000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral repetitive transcranial magnetic stimulation (1 Hz and 10 Hz)
Number of subjects: 30
Study 19894000 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz repetitive transcranial magnetic stimulation
Number of subjects: 30
Study 19894000 — intervention group
Group type: COMPARATOR
Intervention: 10 Hz repetitive transcranial magnetic stimulation
Number of subjects: 30
Study 17762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive contractions (EXPL)
Number of subjects: 9
Study 17762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow contractions (SLOW)
Number of subjects: 9
Study 17762362 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy explosive contractions (HEAVYEXPL)
Number of subjects: 9
Study 17762362 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 9
Study 11015150 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual initiation of TMP/SMX suspension
Number of subjects: 372
Study 11015150 — intervention group
Group type: COMPARATOR
Intervention: Routine initiation of double-strength (DS; 160 mg/800 mg) tablets
Number of subjects: 372
Study 8790092 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated total serum cholesterol levels or serum low-density lipoprotein cholesterol levels
Number of subjects: 2709
Study 8790092 — intervention group
Group type: COMPARATOR
Intervention: Normal serum lipid levels
Number of subjects: 2709
Study 8790092 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of hard exudate
Number of subjects: 2709
Study 1619985 — intervention group
Group type: EXPERIMENTAL
Intervention: E + C (ephedrine 20 mg/caffeine 200 mg)
Number of subjects: 14
Study 1619985 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study 6088300 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 75 mg daily
Number of subjects: 100
Study 6088300 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 100
Study 6088300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30507022 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (iNPWT)
Number of subjects: 876